Eiji Kashiwagi

3.3k total citations
126 papers, 2.6k citations indexed

About

Eiji Kashiwagi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Eiji Kashiwagi has authored 126 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 40 papers in Molecular Biology and 27 papers in Cancer Research. Recurrent topics in Eiji Kashiwagi's work include Prostate Cancer Treatment and Research (72 papers), Prostate Cancer Diagnosis and Treatment (27 papers) and Cancer, Lipids, and Metabolism (24 papers). Eiji Kashiwagi is often cited by papers focused on Prostate Cancer Treatment and Research (72 papers), Prostate Cancer Diagnosis and Treatment (27 papers) and Cancer, Lipids, and Metabolism (24 papers). Eiji Kashiwagi collaborates with scholars based in Japan, United States and China. Eiji Kashiwagi's co-authors include Masaki Shiota, Akira Yokomizo, Seiji Naito, Junichi Inokuchi, Ario Takeuchi, Katsunori Tatsugami, Takeshi Uchiumi, Hiroshi Miyamoto, Masatoshi Eto and Takashi Kawahara and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eiji Kashiwagi

121 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiji Kashiwagi Japan 31 1.3k 943 628 588 565 126 2.6k
Junichi Inokuchi Japan 28 1.1k 0.9× 1.0k 1.1× 478 0.8× 533 0.9× 401 0.7× 161 2.4k
Bora Gürel United States 24 1.4k 1.1× 1.5k 1.6× 661 1.1× 722 1.2× 287 0.5× 57 2.9k
Roberta Mazzucchelli Italy 30 1.1k 0.9× 1.2k 1.3× 521 0.8× 582 1.0× 800 1.4× 145 2.9k
Elaine Kilgour United Kingdom 30 2.3k 1.8× 840 0.9× 949 1.5× 677 1.2× 426 0.8× 80 3.5k
Iris E. Eder Austria 29 1.4k 1.1× 1.5k 1.5× 623 1.0× 728 1.2× 237 0.4× 72 3.0k
Wen‐Lung Ma Taiwan 23 839 0.7× 458 0.5× 326 0.5× 480 0.8× 216 0.4× 68 1.9k
Hans-Juergen Schulten Saudi Arabia 28 764 0.6× 457 0.5× 354 0.6× 337 0.6× 354 0.6× 91 1.9k
Jun‐ichi Akahira Japan 37 1.4k 1.1× 570 0.6× 841 1.3× 756 1.3× 400 0.7× 108 3.6k
Bostjan Humar Switzerland 34 1.3k 1.0× 395 0.4× 576 0.9× 433 0.7× 972 1.7× 74 3.0k
Akiko Kokubu Japan 25 2.2k 1.7× 404 0.4× 649 1.0× 594 1.0× 375 0.7× 29 3.0k

Countries citing papers authored by Eiji Kashiwagi

Since Specialization
Citations

This map shows the geographic impact of Eiji Kashiwagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Kashiwagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Kashiwagi more than expected).

Fields of papers citing papers by Eiji Kashiwagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Kashiwagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Kashiwagi. The network helps show where Eiji Kashiwagi may publish in the future.

Co-authorship network of co-authors of Eiji Kashiwagi

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Kashiwagi. A scholar is included among the top collaborators of Eiji Kashiwagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Kashiwagi. Eiji Kashiwagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blas, Leandro, Masaki Shiota, Shunsuke Goto, et al.. (2023). Fusion‐targeted biopsy significantly improves prostate cancer detection in biopsy‐naïve men. International Journal of Urology. 30(7). 600–604. 4 indexed citations
2.
Blas, Leandro, Masaki Shiota, Fumio Kinoshita, et al.. (2022). Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy. World Journal of Urology. 41(1). 43–50. 3 indexed citations
3.
Takahashi, Ryosuke, Shunichi Kajioka, Eiji Kashiwagi, et al.. (2022). Initial experience with vibegron for the treatment of neurogenic lower urinary tract storage dysfunction in patients with spinal cord injury. SHILAP Revista de lepidopterología. 4. 100516–100516. 2 indexed citations
4.
Shiota, Masaki, Miho Ushijima, Leandro Blas, et al.. (2022). Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot‐assisted radical prostatectomy. International Journal of Urology. 30(4). 340–346. 5 indexed citations
5.
Blas, Leandro, Masaki Shiota, Takashi Matsumoto, et al.. (2022). Impact of nerve sparing in robot‐assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence. International Journal of Urology. 29(8). 824–829. 8 indexed citations
6.
Kashiwagi, Eiji, Masaki Shiota, Kenjiro Imada, et al.. (2022). Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer. International Journal of Urology. 29(10). 1155–1162. 1 indexed citations
7.
Blas, Leandro, Masaki Shiota, Takashi Matsumoto, et al.. (2021). Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer. Anticancer Research. 41(8). 3885–3889. 3 indexed citations
8.
Shiota, Masaki, Leandro Blas, Takashi Matsumoto, et al.. (2021). Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer. Prostate International. 10(1). 50–55. 8 indexed citations
9.
Kashiwagi, Eiji, Toshiya Abe, Masahiro Ushijima, et al.. (2020). The role of adipocytokines and their receptors in bladder cancer: Expression of adiponectin or leptin is an independent prognosticator. European Urology Open Science. 19. e195–e195. 15 indexed citations
10.
Kashiwagi, Eiji, Kenjiro Imada, Fumio Kinoshita, et al.. (2020). Thickness of Perirenal Fat Predicts the Growth Pattern of Renal Cell Carcinoma. 4(1). 41–48. 5 indexed citations
11.
Tanegashima, Tokiyoshi, Yosuke Togashi, Koichi Azuma, et al.. (2019). Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity. Clinical Cancer Research. 25(15). 4808–4819. 69 indexed citations
12.
Kashiwagi, Eiji, Masaki Shiota, Hiroyuki Masaoka, et al.. (2019). Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer. Prostate International. 8(1). 22–26. 10 indexed citations
13.
Shiota, Masaki, Eiji Kashiwagi, Tomohiko Murakami, et al.. (2018). Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 37(3). 180.e19–180.e24. 23 indexed citations
14.
Murakami, Tomohiko, Masaki Shiota, Ario Takeuchi, et al.. (2018). Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer. Anticancer Research. 38(7). 4115–4121. 4 indexed citations
15.
Kashiwagi, Eiji, Satoshi Inoue, Taichi Mizushima, et al.. (2018). MP54-08 PROSTAGLANDIN RECEPTORS INDUCE UROTHELIAL TUMOURIGENESIS AS WELL AS BLADDER CANCER PROGRESSION AND CISPLATIN RESISTANCE PRESUMABLY VIA MODULATING PTEN EXPRESSION. The Journal of Urology. 199(4S). 1 indexed citations
16.
Li, Yi, Hitoshi Ishiguro, Takashi Kawahara, et al.. (2014). Loss of GATA3 in bladder cancer promotes cell migration and invasion. Cancer Biology & Therapy. 15(4). 428–435. 43 indexed citations
17.
Shiota, Masaki, Akira Yokomizo, Ario Takeuchi, et al.. (2013). Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer. Clinical Cancer Research. 20(4). 951–961. 44 indexed citations
18.
Shiota, Masaki, Ario Takeuchi, Akira Yokomizo, et al.. (2012). Methyltransferase Inhibitor Adenosine Dialdehyde Suppresses Androgen Receptor Expression and Prostate Cancer Growth. The Journal of Urology. 188(1). 300–306. 11 indexed citations
19.
Takahashi, Mayu, Shohei Shimajiri, Hiroto Izumi, et al.. (2010). Y‐box binding protein‐1 is a novel molecular target for tumor vessels. Cancer Science. 101(6). 1367–1373. 41 indexed citations
20.
Kashiwagi, Eiji, Hiroto Izumi, Yoshihiro Yasuniwa, et al.. (2010). Enhanced expression of nuclear factor I/B in oxaliplatin‐resistant human cancer cell lines. Cancer Science. 102(2). 382–386. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junichi Inokuchi Breakdown of academic impact, for papers by Bora Gürel Breakdown of academic impact, for papers by Roberta Mazzucchelli Breakdown of academic impact, for papers by Elaine Kilgour Breakdown of academic impact, for papers by Iris E. Eder Breakdown of academic impact, for papers by Wen‐Lung Ma Breakdown of academic impact, for papers by Hans-Juergen Schulten Breakdown of academic impact, for papers by Jun‐ichi Akahira Breakdown of academic impact, for papers by Bostjan Humar Breakdown of academic impact, for papers by Akiko Kokubu
Rankless by CCL
2026